Editorials

The patient voice: measuring what matters in lower-risk myelodysplastic syndromes treated with imetelstat

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
Division of Hematology Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD
Haematologica Early view Feb 26, 2026 https://doi.org/10.3324/haematol.2026.300553